Menstruation and the broader hormonal shifts across the menstrual cycle do affect certain blood test results, though the impact varies widely depending on which test you are looking at. Some markers, like the tumor marker CA-125 and the inflammation marker CRP, can swing enough during menstruation to produce genuinely misleading readings. Others, like standard blood glucose or platelet function, hold relatively steady. The practical question is less “does my period matter?” and more “which specific tests should I worry about?”
Iron and Hemoglobin
This is the most intuitive connection. You lose blood during your period, so it makes sense that iron-related markers would be affected. The relationship is real, but the picture has some nuance worth understanding.
A study of premenopausal blood donors found that menstrual blood loss was a major independent driver of both hemoglobin and ferritin levels. Heavier periods, as measured by a standardized scoring system, were consistently linked to lower hemoglobin and lower iron stores. Women with heavy menstrual bleeding had roughly three and a half times the odds of being anemic compared to those with lighter periods.1PubMed Central. Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors That is a cumulative effect: months or years of heavy bleeding gradually erode iron stores, and this shows up whenever blood is drawn.
A separate question is whether iron markers bounce around noticeably within a single cycle. A study tracking iron biomarkers across the different phases of the menstrual cycle found that ferritin, hemoglobin, and mean corpuscular volume did not change significantly from one phase to the next.2Practical Laboratory Medicine. Cyclical fluctuations of iron biomarkers in women: Diagnostic implications for iron deficiency In other words, getting your blood drawn on day 3 versus day 20 of your cycle probably will not produce a meaningfully different hemoglobin reading. The effect of menstruation on iron is more of a slow drain than a monthly cliff.
The practical takeaway: if you have consistently heavy periods, your iron and hemoglobin results may be chronically lower than they would otherwise be, and this is genuinely caused by your menstrual pattern. But you do not need to schedule a routine complete blood count around a specific cycle day to avoid a misleading result.
CRP and Cardiovascular Risk Assessment
C-reactive protein, or CRP, is an inflammation marker that doctors use for several purposes, including estimating cardiovascular risk. CRP levels shift across the menstrual cycle in a way that can create real diagnostic problems.
Research has shown that CRP values are significantly higher during the early follicular phase (the days around and just after the start of your period) compared to the luteal phase (the second half of the cycle, after ovulation). In one study, the median CRP during the early follicular phase was about 1.8 mg/L, compared to about 0.7 mg/L during the luteal phase.3PubMed Central. CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment That is more than a twofold difference, and it matters because the commonly used cardiovascular risk thresholds for CRP sit in that exact range. A reading of 1.8 mg/L might bump you into a higher risk category, while 0.7 mg/L would place you in a lower one. The same person, same month, genuinely different clinical classification depending on when the blood was drawn.
Interestingly, the erythrocyte sedimentation rate, another inflammation marker often ordered alongside CRP, did not change significantly between cycle phases in the same study. So the cycle effect is specific to CRP rather than a blanket shift in all inflammation markers. If you are having CRP measured specifically for cardiovascular risk stratification, knowing where you are in your cycle is worth mentioning to your doctor. Drawing blood during the luteal phase or mid-cycle, rather than during menstruation, could avoid an artificially elevated result.
The CA-125 Problem
CA-125 is a blood marker used primarily to monitor ovarian cancer and sometimes to help evaluate pelvic masses. It is one of the tests most dramatically affected by menstruation, and the effect is large enough to produce outright false positive results.
Multiple studies have confirmed that CA-125 levels rise significantly during menstruation. One study found that levels were elevated during menses in both healthy women and those with benign conditions, creating a clear source of false positives.4PubMed. Serum CA 125 levels during the menstrual cycle A separate study corroborated this, finding that samples obtained during menses represent a documented source of elevated levels and false positive results.5American Journal of Obstetrics and Gynecology. Serum CA-125 antigen levels increase during menses
How dramatic can this get? In one documented case, a healthy woman’s CA-125 concentration exceeded 300 kU/L during the onset of her period. The normal upper limit is 35 kU/L, so her reading was more than eightfold above that threshold. The elevation subsided to normal by the end of her cycle, and the pattern repeated across several consecutive cycles. Clinical exams and ultrasound found no tumors, and no malignancy was found eight months later.6Clinical Chemistry. Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation
That case is extreme, but it illustrates a real clinical pitfall. If you are premenopausal and your doctor orders a CA-125 test, scheduling the blood draw for well after your period ends (not during or immediately before menstruation) avoids what could be a very stressful false alarm.
Blood Glucose
Blood sugar is one of the more debated areas, partly because different measurement methods tell slightly different stories.
A study using continuous glucose monitors found that glucose levels are lowest during the late follicular phase (around day 13 or 14 of the cycle, just before ovulation) and highest during the luteal phase, with a gradual increase through ovulation. The differences were statistically significant: compared to the late-follicular low point, average glucose was modestly higher during ovulation, the luteal phase, and menstruation itself.7npj digital medicine. Blood glucose variance measured by continuous glucose monitors across the menstrual cycle The absolute shifts were small, roughly a few tenths of a mmol/L, but they were consistent and measurable.
On the other hand, an older study that directly tested glucose tolerance found that fasting glucose, insulin, and C-peptide levels did not differ between cycle phases, and concluded that the menstrual cycle has no major effect on glucose tolerance or insulin secretion in nondiabetic women. That study specifically argued that the phase of the menstrual cycle should not need to be considered when programming or interpreting an oral glucose tolerance test.8PubMed. Influence of the menstrual cycle on glucose tolerance and insulin secretion
These findings are not as contradictory as they sound. Continuous glucose monitoring captures 24-hour patterns including post-meal spikes, while a formal glucose tolerance test measures the body’s response to a standardized sugar load under controlled conditions. The cycle appears to produce subtle shifts in day-to-day glucose patterns, but not enough to meaningfully alter the outcome of a diagnostic test for diabetes. If you are doing a fasting glucose or oral glucose tolerance test, you probably do not need to worry about cycle timing. If you are tracking glucose continuously for reasons related to insulin sensitivity or metabolic health, the luteal-phase uptick is real and worth knowing about.
Cortisol
Cortisol, the body’s primary stress hormone, also fluctuates across the menstrual cycle. A study measuring cortisol at rest and in response to maximal exercise found that cortisol levels were significantly higher during the follicular phase (about 11.0 µg/dL on average) compared to the luteal phase (about 8.6 µg/dL).9PubMed Central. Effects of the Menstrual Cycle Phase on Cortisol Responses to Maximum Exercise in Women With and Without Premenstrual Syndrome This pattern held regardless of whether participants had premenstrual syndrome.
A difference of that magnitude could matter if cortisol is being tested to evaluate adrenal function or a suspected cortisol disorder. A follicular-phase reading might look mildly elevated compared to the reference range, while a luteal-phase reading from the same person might look perfectly normal. For one-off cortisol tests, cycle timing is worth noting on the lab requisition.
Thyroid and Platelet Tests Hold Steady
Not everything moves with the cycle, and it is useful to know which common tests you do not need to worry about scheduling around your period.
A longitudinal study of premenopausal women found that thyroid hormone levels were not meaningfully associated with cycle phase. While there was a faint suggestion that free T4 might relate to overall cycle length, the differences were small and confidence intervals overlapped heavily. Bleed length and intensity were also unrelated to thyroid hormone levels.10PubMed Central. Thyroid hormones and menstrual cycle function in a longitudinal cohort of premenopausal women If you are having your thyroid checked, cycle day does not matter.
Similarly, platelet function testing does not appear to shift between menstruation and other cycle phases. A study comparing platelet closure times during menstruation versus the luteal phase found no statistically significant differences.11PubMed Central. Modulation of Platelet Functions Assessment during Menstruation and Ovulatory Phases This is reassuring if you need coagulation or platelet testing and happen to be menstruating.
What Oral Contraceptives Change
Hormonal contraceptives are a separate but related consideration, because they alter the hormonal landscape that drives many of these cycle-related shifts while also having their own direct effects on blood parameters.
A review of the hematological effects of oral contraceptives found that most users had higher hemoglobin, platelet counts, and red blood cell counts compared to nonusers. This likely reflects the lighter or absent menstrual bleeding typical of hormonal contraception, which reduces chronic iron loss. On the coagulation side, oral contraceptive users tended to have shorter prothrombin times and activated partial thromboplastin times, plus higher levels of fibrinogen and D-dimer, compared to nonusers.12PubMed Central. Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review White blood cell counts and differentials did not change significantly.
The clotting-related changes deserve attention. Higher fibrinogen and D-dimer, along with shorter clotting times, reflect the well-known prothrombotic effect of estrogen-containing contraceptives. If you are on oral contraceptives and get a D-dimer test for suspected blood clots, a mildly elevated result may be harder to interpret. This is something your doctor should already be aware of, but it is worth flagging if they do not know you are on hormonal birth control.
It is also worth noting that the levonorgestrel-releasing intrauterine device (a progestin-only option that dramatically reduces menstrual bleeding) was associated with much lower odds of iron deficiency in the blood donor study mentioned earlier.1PubMed Central. Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors Contraceptive choices do not just suppress the cycle; they meaningfully reshape your baseline lab profile.
Urine Tests and Menstrual Contamination
Blood tests are not the only ones affected. If you provide a urine sample while menstruating, menstrual blood can contaminate the specimen and produce a false-positive result for blood in the urine (hematuria). This is a well-recognized problem in clinical practice. A positive dipstick result for blood during your period does not necessarily mean anything is wrong with your urinary tract; it may simply be menstrual contamination. Most labs and clinicians will ask about menstrual timing or recommend retesting after your period ends if the result is ambiguous. A clean-catch midstream technique can help, but it does not always prevent contamination entirely.
When to Schedule and What to Tell Your Doctor
Given all of the above, the tests most sensitive to menstrual cycle timing are CRP (for cardiovascular risk), CA-125 (for tumor screening), and cortisol. For these three, scheduling your blood draw during the mid-follicular to mid-luteal window, well away from menstruation itself, reduces the chance of a misleading result. If you cannot control the timing, simply telling your doctor what cycle day you are on gives them the context to interpret results more carefully.
For routine tests like a complete blood count, thyroid panel, fasting glucose, or basic metabolic panel, the cycle has minimal or no clinically meaningful effect on a single blood draw. You do not need to reschedule these around your period. The exception is if you have very heavy menstrual bleeding and are being evaluated for anemia: in that case, your results are not being distorted by timing; they are accurately reflecting the chronic impact of blood loss, and that is exactly what your doctor needs to see.
If you are on hormonal contraception, your lab results already reflect a different baseline than a naturally cycling person. This does not make the results wrong, but it does mean reference ranges derived from mixed populations may not perfectly apply to you. Mentioning your contraceptive method when blood work is ordered helps your doctor interpret results like hemoglobin, clotting times, and D-dimer in the right context.
Reproductive Hormones Are Supposed to Fluctuate
One area where cycle timing is obviously central but sometimes poorly communicated is reproductive hormone testing itself. Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone all have dramatically different normal values depending on which cycle day the blood is drawn. A progesterone level that looks normal on day 21 would be abnormally high on day 5. Doctors ordering these tests should specify the cycle day for the draw, but patients are not always told why the timing matters, and results can be confusing if the lab report shows a standard reference range rather than a phase-specific one.
Research using daily hormone tracking has shown that population-level hormone data, combined with a person’s age and reported first cycle day, can pinpoint cycle phase with high confidence.13PubMed Central. Using Hormone Data and Age to Pinpoint Cycle Day within the Menstrual Cycle This kind of precision matters because a hormone value is nearly meaningless without knowing where in the cycle it was drawn. If you are having fertility hormones tested and are not given specific instructions about which cycle day to come in, ask. A result drawn on the wrong day is not useful for diagnosis.
Vitamin D and Menstrual Health
While most of this article covers how the menstrual cycle affects lab results, the reverse relationship is also worth a mention. Low vitamin D status appears to be linked to menstrual irregularities. A study of young women found that those with vitamin D levels below 30 ng/mL had roughly five times the odds of menstrual cycle disorders, including infrequent or absent periods, compared to women above that threshold.14PubMed Central. The Relationship between Vitamin D Status and the Menstrual Cycle in Young Women: A Preliminary Study This was a small preliminary study, so the exact magnitude of that risk is uncertain. But it is a reminder that lab values and menstrual health interact in both directions: your cycle can influence your results, and your nutritional status can influence your cycle.